Phibro Animal Health | PAHC - 营业利润

股票价格

54.81

每天变化

-1.70 -3.01%

每月一次

1.88%

每年

221.65%

Q2 预测

55.81

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.29B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	营业利润	更改		日
Align Technology	USD 224.71M		40.06M	2025-12
ANI Pharmaceuticals	USD 29.13M		6.3M	2025-12
Assertio Holdings	USD -3.05M		569K	2024-09
Aurora Cannabis	CAD -35.79M		19.88M	2025-12
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Corcept Therapeutics	USD 4.49M		5.73M	2025-12
Eli Lilly	USD 8.99B		599.9M	2025-12
Henry Schein	USD 186M		12M	2025-12
Idexx Laboratories	USD 315.6M		39.24M	2025-12
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Merck	USD 6.24B		318M	2025-12
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Pacira	USD 3.19M		9.96M	2025-12
Phibro Animal Health	USD 54.99M		2.36M	2025-12
Prestige Brands	USD 82.49M		2.82M	2025-12
Supernus Pharmaceuticals	USD 13.82M		74.01M	2025-12
Zoetis	USD 835M		101M	2025-12